Walter Reed Amy Institute of Research
Welcome,         Profile    Billing    Logout  
 5 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Beckett, Charmagne
NCT05626803: A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Active, not recruiting
2
135
US
Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 medium dose vaccine 1×10 to the power 11 IU/dose, Placebo
Vaxart
Norovirus Infections
10/23
07/24
Koren, Michael J
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
NCT06142383: A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

Terminated
2
136
Europe, Japan, US, RoW
Placebo, XXB750 Low dose, XXB750 Medium Dose, XXB750 High Dose, Sacubitril/valsartan
Novartis Pharmaceuticals
Heart Failure
11/24
11/24
Cycle-2-PEF, NCT06215586: Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction

Recruiting
2
240
Europe, Canada, US, RoW
Tovinontrine (CRD-750, Placebo
Cardurion Pharmaceuticals, Inc.
Heart Failure, Heart Failure Preserved Ejection Fraction, Cardiovascular Diseases, Heart Diseases
10/25
10/25
Cycle-1-REF, NCT06215911: A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction

Recruiting
2
400
Europe, Canada, US, RoW
Tovinontrine (CRD-750), Placebo
Cardurion Pharmaceuticals, Inc.
Heart Failure, Heart Failure With Reduced Ejection Fraction, Cardiovascular Diseases, Heart Diseases
10/25
10/25
DETECT-HF, NCT06378632: AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

Recruiting
N/A
500
Europe, US, RoW
Hearo App
Cordio Medical
Heart Failure
01/25
03/25
NCT05646056: A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk

Completed
N/A
82
US
Software
Prolaio
Heart Failure, Cardiomyopathy, Hypertrophic, Left Ventricular Hypertrophy
09/24
09/24

Download Options